Skip to main content
. 2020 Oct 15;5(20):e139987. doi: 10.1172/jci.insight.139987

Figure 9. Effect of systemic tail vein administration of TL02-59 on autologous blood microinjection–induced thalamic activation of NF-κB and ERK1/2 pathways and production of TNF-α.

Figure 9

Expression of Iba1 and GFAP in the cytoplasmic fraction (A), expression of p-p65 and p-65 in the nuclear fraction (B), expression of p-ERK1/2 and ERK1/2 in the cytoplasmic fraction (C) and expression of p65 (total-p65) and TNF-α in the total cellular fraction (D) from the ipsilateral thalamus of the different treatment groups on day 3 after thalamic microinjection of autologous blood or saline. Top: representative Western blots. Bottom: statistical summary of the densitometric analysis. n = 3 biological repeats/group. Two-way ANOVA with repeated measures followed by post hoc Tukey’s test. **P < 0.01 versus the corresponding saline plus vehicle–treated group. ##P < 0.01 versus the corresponding autologous blood plus vehicle–treated group.